Trial Outcomes & Findings for Skin Protectant Textile Efficacy Study for Managing Skin Fold Conditions (NCT NCT05742347)

NCT ID: NCT05742347

Last Updated: 2025-05-21

Results Overview

The efficacy of the SPT to improve skinfold condition of erythema over three days of treatment were assessed by third party clinicians using a 5-point Likert scales, with "0" being least severe and "4" being most severe. Data is reported as the mean and standard deviation on the scale for each timepoint.

Recruitment status

TERMINATED

Study phase

NA

Target enrollment

47 participants

Primary outcome timeframe

day 0, day 1, day 3

Results posted on

2025-05-21

Participant Flow

Enrollment was based on the total number of target areas for review. A minimum of 80 target areas were required to complete the enrollment.

Unit of analysis: target areas

Participant milestones

Participant milestones
Measure
DriGo SPT
All participants will have the DriGo skin protectant textile applied to their skin fold condition. DriGo Skin Protectant Textile: All participants in this study will have the DriGo skin protectant textile applied to their skin fold condition. Erythema, denudation, maceration, odor, and moisture will be assessed following application of the SPT.
Overall Study
STARTED
47 83
Overall Study
COMPLETED
46 82
Overall Study
NOT COMPLETED
1 1

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Race and Ethnicity were not collected from any participant.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
DriGo SPT
n=46 Participants
All participants will have the DriGo skin protectant textile applied to their skin fold condition. DriGo Skin Protectant Textile: All participants in this study will have the DriGo skin protectant textile applied to their skin fold condition. Erythema, denudation, maceration, odor, and moisture will be assessed following application of the SPT.
Age, Continuous
67.61 years
STANDARD_DEVIATION 10.90 • n=46 Participants
Sex: Female, Male
Female
37 Participants
n=46 Participants
Sex: Female, Male
Male
9 Participants
n=46 Participants
Region of Enrollment
United States
46 Participants
n=46 Participants

PRIMARY outcome

Timeframe: day 0, day 1, day 3

Population: Individuals ≥ 18 years of age. who have evidence of one or more of the following skin fold conditions: erythema, maceration, denudation, satellite lesions, pain, itching, burning, moisture, and odor

The efficacy of the SPT to improve skinfold condition of erythema over three days of treatment were assessed by third party clinicians using a 5-point Likert scales, with "0" being least severe and "4" being most severe. Data is reported as the mean and standard deviation on the scale for each timepoint.

Outcome measures

Outcome measures
Measure
DriGo SPT
n=46 Participants
All participants will have the DriGo skin protectant textile applied to their skin fold condition. DriGo Skin Protectant Textile: All participants in this study will have the DriGo skin protectant textile applied to their skin fold condition. Erythema, denudation, maceration, odor, and moisture will be assessed following application of the SPT.
Summary Statistics of HCP
Summary Statistics of HCP: SPT helped alleviate the skin fold conditions of my patient.
Summary Statistics of HCP Was Easy to Apply
Summary Statistics of: SPT was easy to apply - VAS score 0-100 mm
Summary Statistics of: I Would Recommend DriGo to Others.
Summary Statistics of: I would recommend DriGo to others. Using VAS score 0-100 mm
Erythema
Day 0
2.15 units on a scale
Standard Deviation .82
Erythema
Day 1
2.15 units on a scale
Standard Deviation 0.72
Erythema
Day 3
.78 units on a scale
Standard Deviation .81

PRIMARY outcome

Timeframe: day 0, day 1, day 3.

Population: Individuals ≥ 18 years of age. who have evidence of one or more of the following skin fold conditions: erythema, maceration, denudation, satellite lesions, pain, itching, burning, moisture, and odor

The efficacy of the SPT to improve skinfold conditions of maceration over three days of treatment were assessed by third party clinician using a 5-point Likert scales, with "0" being least severe and "4" being most severe. Data is reported as the mean and standard deviation values from the scale for each timepoint measured.

Outcome measures

Outcome measures
Measure
DriGo SPT
n=46 Participants
All participants will have the DriGo skin protectant textile applied to their skin fold condition. DriGo Skin Protectant Textile: All participants in this study will have the DriGo skin protectant textile applied to their skin fold condition. Erythema, denudation, maceration, odor, and moisture will be assessed following application of the SPT.
Summary Statistics of HCP
Summary Statistics of HCP: SPT helped alleviate the skin fold conditions of my patient.
Summary Statistics of HCP Was Easy to Apply
Summary Statistics of: SPT was easy to apply - VAS score 0-100 mm
Summary Statistics of: I Would Recommend DriGo to Others.
Summary Statistics of: I would recommend DriGo to others. Using VAS score 0-100 mm
Maceration
Day 0
0.73 units on a scale
Standard Deviation 0.82
Maceration
Day 1
0.49 units on a scale
Standard Deviation 0.65
Maceration
Day 3
0.45 units on a scale
Standard Deviation 0.64

PRIMARY outcome

Timeframe: day 0, day 1, and day 3.

Population: Individuals ≥ 18 years of age. who have evidence of one or more of the following skin fold conditions: erythema, maceration, denudation, satellite lesions, pain, itching, burning, moisture, and odor

The efficacy of the SPT to improve skinfold conditions denudation were assessed over 3 days by a third party clinician using a 5-point Likert scales, with "0" being least severe and "4" being most severe. Data is reported as the mean and standard deviation value on the scale for each timepoint measured.

Outcome measures

Outcome measures
Measure
DriGo SPT
n=46 Participants
All participants will have the DriGo skin protectant textile applied to their skin fold condition. DriGo Skin Protectant Textile: All participants in this study will have the DriGo skin protectant textile applied to their skin fold condition. Erythema, denudation, maceration, odor, and moisture will be assessed following application of the SPT.
Summary Statistics of HCP
Summary Statistics of HCP: SPT helped alleviate the skin fold conditions of my patient.
Summary Statistics of HCP Was Easy to Apply
Summary Statistics of: SPT was easy to apply - VAS score 0-100 mm
Summary Statistics of: I Would Recommend DriGo to Others.
Summary Statistics of: I would recommend DriGo to others. Using VAS score 0-100 mm
Denudation
Day 0
0.88 units on a scale
Standard Deviation 0.84
Denudation
Day 1
0.60 units on a scale
Standard Deviation 0.66
Denudation
Day 3
0.20 units on a scale
Standard Deviation 0.44

PRIMARY outcome

Timeframe: 5 days

Population: Individuals ≥ 18 years of age. who have evidence of one or more of the following skin fold conditions: erythema, maceration, denudation, satellite lesions, pain, itching, burning, moisture, and odor

The efficacy of the SPT to improve skinfold conditions of satellite lesions were assessed by a third party clinician as absent or present each day over 5 days. Results for present lesions detected presented below. Data is reported as the percentage of participants identified with any satellite lesions.

Outcome measures

Outcome measures
Measure
DriGo SPT
n=46 Participants
All participants will have the DriGo skin protectant textile applied to their skin fold condition. DriGo Skin Protectant Textile: All participants in this study will have the DriGo skin protectant textile applied to their skin fold condition. Erythema, denudation, maceration, odor, and moisture will be assessed following application of the SPT.
Summary Statistics of HCP
Summary Statistics of HCP: SPT helped alleviate the skin fold conditions of my patient.
Summary Statistics of HCP Was Easy to Apply
Summary Statistics of: SPT was easy to apply - VAS score 0-100 mm
Summary Statistics of: I Would Recommend DriGo to Others.
Summary Statistics of: I would recommend DriGo to others. Using VAS score 0-100 mm
Satellite Lesions
day 0
5 participants
Satellite Lesions
day 1
5 participants
Satellite Lesions
day 3
3 participants
Satellite Lesions
day 5
0 participants

PRIMARY outcome

Timeframe: Day 0, day 1, day 3 and day 5

Population: Individuals ≥ 18 years of age. who have evidence of one or more of the following skin fold conditions: erythema, maceration, denudation, satellite lesions, pain, itching, burning, moisture, and odor

The efficacy of the SPT to improve skinfold conditions of odor over five days of treatment was assessed by a third party clinician as absent or present with values for present noted below. Data is presented as the percentage of participants identified with any odor at the target area for each timepoint measured.

Outcome measures

Outcome measures
Measure
DriGo SPT
n=46 Participants
All participants will have the DriGo skin protectant textile applied to their skin fold condition. DriGo Skin Protectant Textile: All participants in this study will have the DriGo skin protectant textile applied to their skin fold condition. Erythema, denudation, maceration, odor, and moisture will be assessed following application of the SPT.
Summary Statistics of HCP
Summary Statistics of HCP: SPT helped alleviate the skin fold conditions of my patient.
Summary Statistics of HCP Was Easy to Apply
Summary Statistics of: SPT was easy to apply - VAS score 0-100 mm
Summary Statistics of: I Would Recommend DriGo to Others.
Summary Statistics of: I would recommend DriGo to others. Using VAS score 0-100 mm
Odor
Odor Present day 0
23 participants
Odor
Odor present day 1
11 participants
Odor
Odor present day 3
12 participants
Odor
odor present day 5
10 participants

SECONDARY outcome

Timeframe: Day 0, day 1, day 3, and day 5

Population: Individuals ≥ 18 years of age. who have evidence of one or more of the following skin fold conditions: erythema, maceration, denudation, satellite lesions, pain, itching, burning, moisture, and odor

survey responses for moisture in the target area(s) on Day 0, and on Days 1, 3, and 5, during SPT changes, third party clinicians assessed the moisture as either abscent/scant or small/moderate. All other patients were coded as not able to detect. Data is presented as the percentage of participants with abscent/scant moisture at each timepoint and the percentage of participants with small/moderate moisture at each timepoint.

Outcome measures

Outcome measures
Measure
DriGo SPT
n=46 Participants
All participants will have the DriGo skin protectant textile applied to their skin fold condition. DriGo Skin Protectant Textile: All participants in this study will have the DriGo skin protectant textile applied to their skin fold condition. Erythema, denudation, maceration, odor, and moisture will be assessed following application of the SPT.
Summary Statistics of HCP
Summary Statistics of HCP: SPT helped alleviate the skin fold conditions of my patient.
Summary Statistics of HCP Was Easy to Apply
Summary Statistics of: SPT was easy to apply - VAS score 0-100 mm
Summary Statistics of: I Would Recommend DriGo to Others.
Summary Statistics of: I would recommend DriGo to others. Using VAS score 0-100 mm
Survey Responses for Moisture in the Target Area(s) on Assessment of Moisture Control.
Moisture absent/scant day 0
15 participants
Survey Responses for Moisture in the Target Area(s) on Assessment of Moisture Control.
Moisture small/moderate day 0
20 participants
Survey Responses for Moisture in the Target Area(s) on Assessment of Moisture Control.
Moisture absent/scant day 1
13 participants
Survey Responses for Moisture in the Target Area(s) on Assessment of Moisture Control.
Moisture small/moderate day 1
16 participants
Survey Responses for Moisture in the Target Area(s) on Assessment of Moisture Control.
Moisture absent/scant day 3
15 participants
Survey Responses for Moisture in the Target Area(s) on Assessment of Moisture Control.
Moisture small/moderate day 3
7 participants
Survey Responses for Moisture in the Target Area(s) on Assessment of Moisture Control.
Moisture absent/scant day 5
10 participants
Survey Responses for Moisture in the Target Area(s) on Assessment of Moisture Control.
Moisture small/moderate day 5
4 participants

SECONDARY outcome

Timeframe: day 0, day 1, day 3

Population: Individuals ≥ 18 years of age. who have evidence of one or more of the following skin fold conditions: erythema, maceration, denudation, satellite lesions, pain, itching, burning, moisture, and odor

Assessing Patient reported outcomes before the dressing change - VAS score 0-100 mm with 0 being the least amount of pain and 100 being the most painful.

Outcome measures

Outcome measures
Measure
DriGo SPT
n=46 Participants
All participants will have the DriGo skin protectant textile applied to their skin fold condition. DriGo Skin Protectant Textile: All participants in this study will have the DriGo skin protectant textile applied to their skin fold condition. Erythema, denudation, maceration, odor, and moisture will be assessed following application of the SPT.
Summary Statistics of HCP
Summary Statistics of HCP: SPT helped alleviate the skin fold conditions of my patient.
Summary Statistics of HCP Was Easy to Apply
Summary Statistics of: SPT was easy to apply - VAS score 0-100 mm
Summary Statistics of: I Would Recommend DriGo to Others.
Summary Statistics of: I would recommend DriGo to others. Using VAS score 0-100 mm
Assessing Patient Reported Outcomes of Discomfort (Pain, Itching, Burning) Before Dressing Change
Discomfort (Pain, Itching, or Burning) experienced before the dressing change. Day 0
17 score on a scale - VAS score 0-100 mm
Standard Deviation 34
Assessing Patient Reported Outcomes of Discomfort (Pain, Itching, Burning) Before Dressing Change
Discomfort (Pain, Itching, or Burning) experienced before the dressing change. Day 1
0 score on a scale - VAS score 0-100 mm
Standard Deviation 23
Assessing Patient Reported Outcomes of Discomfort (Pain, Itching, Burning) Before Dressing Change
Discomfort (Pain, Itching, or Burning) experienced before the dressing change. Day 3
0 score on a scale - VAS score 0-100 mm
Standard Deviation 22

SECONDARY outcome

Timeframe: day 0, day 1, day3

Population: Individuals ≥ 18 years of age. who have evidence of one or more of the following skin fold conditions: erythema, maceration, denudation, satellite lesions, pain, itching, burning, moisture, and odor

Assessing patient reported outcomes of discomfort (Pain, Itching, or Burning) experienced after the dressing change Patient Reported Outcomes: VAS score 0-100 mm with 0 being the least painful and 100 being the most painful

Outcome measures

Outcome measures
Measure
DriGo SPT
n=46 Participants
All participants will have the DriGo skin protectant textile applied to their skin fold condition. DriGo Skin Protectant Textile: All participants in this study will have the DriGo skin protectant textile applied to their skin fold condition. Erythema, denudation, maceration, odor, and moisture will be assessed following application of the SPT.
Summary Statistics of HCP
Summary Statistics of HCP: SPT helped alleviate the skin fold conditions of my patient.
Summary Statistics of HCP Was Easy to Apply
Summary Statistics of: SPT was easy to apply - VAS score 0-100 mm
Summary Statistics of: I Would Recommend DriGo to Others.
Summary Statistics of: I would recommend DriGo to others. Using VAS score 0-100 mm
Patient Report of Pain Itching or Burning After Dressing Change Day 0, Day 1, and Day 3
discomfort (Pain, Itching, or Burning) experienced after the dressing change Day 3
8.1 score on a scale - VAS score 0-100 mm
Standard Deviation 17
Patient Report of Pain Itching or Burning After Dressing Change Day 0, Day 1, and Day 3
discomfort (Pain, Itching, or Burning) experienced after the dressing change Day 0
24.7 score on a scale - VAS score 0-100 mm
Standard Deviation 32
Patient Report of Pain Itching or Burning After Dressing Change Day 0, Day 1, and Day 3
discomfort (Pain, Itching, or Burning) experienced after the dressing change Day 1
10.6 score on a scale - VAS score 0-100 mm
Standard Deviation 18

SECONDARY outcome

Timeframe: Day 5

Population: ndividuals ≥ 18 years of age. who have evidence of one or more of the following skin fold conditions: erythema, maceration, denudation, satellite lesions, pain, itching, burning, moisture, and odor

Summary Statistics of: The dressing significantly reduced discomfort (Pain, Itching, and Burning) in the skin-on-skin contact area (target area) at Day 5 with 0 being not at all and 100 being absolutely yes it helped reduce my discomfort.

Outcome measures

Outcome measures
Measure
DriGo SPT
n=46 Participants
All participants will have the DriGo skin protectant textile applied to their skin fold condition. DriGo Skin Protectant Textile: All participants in this study will have the DriGo skin protectant textile applied to their skin fold condition. Erythema, denudation, maceration, odor, and moisture will be assessed following application of the SPT.
Summary Statistics of HCP
Summary Statistics of HCP: SPT helped alleviate the skin fold conditions of my patient.
Summary Statistics of HCP Was Easy to Apply
Summary Statistics of: SPT was easy to apply - VAS score 0-100 mm
Summary Statistics of: I Would Recommend DriGo to Others.
Summary Statistics of: I would recommend DriGo to others. Using VAS score 0-100 mm
Did the Product Reduce Your Discomfort Assessed at Discharge Day 5
98 score on a scale VAS score 0-100 mm
Standard Deviation 23

SECONDARY outcome

Timeframe: Day 5

Population: Individuals ≥ 18 years of age. who have evidence of one or more of the following skin fold conditions: erythema, maceration, denudation, satellite lesions, pain, itching, burning, moisture, and odor

Summary Statistics of: The dressing was comfortable to wear at at Day 5. VAS score 0-100 mm with 0 being not at all comfortable and 100 being the most comfortable.

Outcome measures

Outcome measures
Measure
DriGo SPT
n=46 Participants
All participants will have the DriGo skin protectant textile applied to their skin fold condition. DriGo Skin Protectant Textile: All participants in this study will have the DriGo skin protectant textile applied to their skin fold condition. Erythema, denudation, maceration, odor, and moisture will be assessed following application of the SPT.
Summary Statistics of HCP
Summary Statistics of HCP: SPT helped alleviate the skin fold conditions of my patient.
Summary Statistics of HCP Was Easy to Apply
Summary Statistics of: SPT was easy to apply - VAS score 0-100 mm
Summary Statistics of: I Would Recommend DriGo to Others.
Summary Statistics of: I would recommend DriGo to others. Using VAS score 0-100 mm
The Product Dressing Was Comfortable to Wear
96 score on a scale - VAS score 0-100 mm
Standard Deviation 8.9

SECONDARY outcome

Timeframe: End of the study on day 5

Population: HCP

Summary Statistics of HCP: Instructions for application of the skin protectant textile (SPT) were easy to understand. Health care practioniers (HCPs) answered a series of questions regarding the instructions for the product. Each question answered on a scale of 0-100 with 0 being negative/difficult/not likely to reccomend and 100 being positive/easy to use/likely to reccomend to others. Data is reported as the mean value for the question asked based on the scale value of 0-100. These questions were only asked of the HCP at the end of the study on day 5.

Outcome measures

Outcome measures
Measure
DriGo SPT
n=40 Participants
All participants will have the DriGo skin protectant textile applied to their skin fold condition. DriGo Skin Protectant Textile: All participants in this study will have the DriGo skin protectant textile applied to their skin fold condition. Erythema, denudation, maceration, odor, and moisture will be assessed following application of the SPT.
Summary Statistics of HCP
n=40 Participants
Summary Statistics of HCP: SPT helped alleviate the skin fold conditions of my patient.
Summary Statistics of HCP Was Easy to Apply
n=40 Participants
Summary Statistics of: SPT was easy to apply - VAS score 0-100 mm
Summary Statistics of: I Would Recommend DriGo to Others.
n=40 Participants
Summary Statistics of: I would recommend DriGo to others. Using VAS score 0-100 mm
Summary Statistics of HCP - HCP Reported Ease of Use: VAS Score 0-100 mm
93 score on a scale - VAS score 0-100 mm
Standard Deviation 12
89 score on a scale - VAS score 0-100 mm
Standard Deviation 20
97 score on a scale - VAS score 0-100 mm
Standard Deviation 6.8
94 score on a scale - VAS score 0-100 mm
Standard Deviation 18

Adverse Events

All Participants

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Julie J. Finley

Medline Industries, LP

Phone: (800) 33-5463

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place

Restriction type: GT60